The AGM could be short & sweet if......there is positive news on these two fronts/ catalysts to move the share: 1) Announcement of a strong partner (or, reference to a shortlist and a near-term decision date) 2) VCM has been sold at a decent price (or...ditto) Others of interest: 3) New listing, south of the border, forthcoming for Telesta Therapeutics Inc. 4) Professional PR campaign announced 5) Acquisition discussion (being acquired side). But I have to believe a long shot and likely not be in the best interest for shareholders at this stage. And, last but not least...will stick around to hear the answer to HT's question re: "cost per doze and number of dozes?" Overall, I have seen a lot of necessary and right actions. HUGE positive surprise in July re FDA's guidance permitting submission of an MCNA BLA; Disappointment that a major partner has not already been announced (as we were told at last AGM waiting for FDA guidance first in order to command significantly more from a potential partner); And, very disappointed with the recent financing....feel like I own something based in Russian roubles. GLTA, enjoy wk-end and hopefully the AGM (with a catalyst as sure is needed!) rg P.S...I guess any catalyst-oriented news would have to be announced prior to market opening of the morning of AGM. Pls correct me if I am mistaken on this.